Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT and Diet for Type 2 Diabetes in Obese Patients
NCT02346669Phase 2Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Apr 2016
- Primary completion
- Jan 2018
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of allogeneic fecal microbiota in type 2 diabetes mellitus (T2DM), sponsored by Tel Aviv Sourasky Medical Center. Status: unknown.
02
Drugs
allogeneic fecal microbiota
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02346669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02346669.